Novidades Científicas

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) – Long Term Outcomes


Ler mais

Hospital Performance Based on 30-Day Risk Standardized Mortality and Long-Term Survival after Hearth Failure Hospitalization an Analysis of the GWTG-HF Registry


Ler mais

Lower Risk of Cardiovascular Events and Death Associated with Initiation of SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs – Real World Data Across Three Major World Regions With More Than 400.000 Patients: The CVD-REAL 2 Study


Ler mais

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)


Ler mais

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study


Ler mais

European Society of Cardiology: Cardiovascular Disease Statistics 2017


Ler mais

European Cardiovascular Disease Statistics 2017


Ler mais

CETP inhibitor meets primary endpoint in CV outcome study


Ler mais

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial


Ler mais

A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS


Ler mais

Página 2 de 4

Login

Lembrar


Criar novo registo

Lost Password

NOVO REGISTO

Challenges in Cardiology